Fundraising FoxGRA Venture — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Altesa BioSciencesaltesabio.comFeb 2026
Altesa BioSciences is a clinical-stage pharmaceutical company developing vapendavir, an orally administered antiviral targeting rhinovirus infections in patients with chronic lung diseases such as COPD and asthma.
BiotechHealthtechCollege Park, US
John Clerici(Executive Officer)inAndrew Drechsler(Executive Officer)Brett Giroir(Executive Officer, Director)
BoardNicholas Williams(Director)Moncef Slaoui(Director)Jon Edwards(Director)in
Co-investorsForbionMedicxiPitangoSanofi Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.